Patients or their clinical team can use the platform independently, on their computer, tablet or cell phone. At regular intervals, patients complete a monitoring questionnaire specific to their treatment or protocol.
After analysis of the responses by our medical device, an alert is generated for the care teams, and an appropriate guidance message is sent to the patient, along with therapeutic advice to help manage grade 1 and 2 adverse events.
Patient information content and digital supportive care are also accessible via the app.
For the few patients who cannot or do not wish to use the application, a phone monitoring module is available.
A member of the care team can enter the patients responses to the questionnaire during a phone call with the patient.
Following analysis of the responses by our medical device, an alert is generated for the care teams. The entire patient cohort can thus be remotely monitored via our platform.
The “OK-Chemo” module collates patients’ reported toxicities and blood test results one or two days before their scheduled appointments.
This is used to pre-validate patients’ chemotherapy appointments at the outpatient department.
Dr. Noémie STUDDER, support care and patient pathways manager
Joana ROSE, coordinating nurse
Dr. Thomas FEUTREN, radiotherapist oncologist